Susan Born, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 529 Main St, Suite 216, Charlestown, MA 02129 Phone: 617-426-0600 |
Theresa Walsh, Registered Nurse - Case Management Medicare: Not Enrolled in Medicare Practice Location: 529 Main St, Charlestown, MA 02129 Phone: 616-600-3195 |
Ms. Amanda Durgin, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 529 Main St, Suite 216, Charlestown, MA 02129 Phone: 617-600-3195 |
Brian Henry, AGACNP-BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 529 Main St, Suite 216, Charlestown, MA 02129 Phone: 617-426-0600 |
Julia Tatum Mcandrew, MSN, MPH, FNP-BC Registered Nurse Medicare: May Accept Medicare Assignments Practice Location: 15 Tufts St, Charlestown, MA 02129 Phone: 587-238-1100 Fax: 857-238-1170 |
Tracey Marie Calixto, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 529 Main St Ste 222, Charlestown, MA 02129 Phone: 617-426-0600 |
James Foley, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 529 Main St, Charlestown, MA 02129 Phone: 857-303-6208 Fax: 617-924-1207 |
Mrs. Danielle Hannigan, DIRECTOR OF NURSING Registered Nurse - General Practice Medicare: Not Enrolled in Medicare Practice Location: 529 Main St Ste 243, Charlestown, MA 02129 Phone: 617-870-1676 Fax: 617-412-3004 |
Kristina M Devine, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 529 Main St, Charlestown, MA 02129 Phone: 617-426-0600 |
Katherine Mathews, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 300 1st Ave, Charlestown, MA 02129 Phone: 617-952-5000 |
Juliet Tatiana Franco-cooper, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 529 Main St, Charlestown, MA 02129 Phone: 866-610-2273 |
Doris Labbe, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 529 Main St, Charlestown, MA 02129 Phone: 866-610-2273 |
Kelly Allen, Registered Nurse - Case Management Medicare: Not Enrolled in Medicare Practice Location: 529 Main St Ste 222, Charlestown, MA 02129 Phone: 866-610-2273 |
Mia Christine Giles, Registered Nurse Medicare: Medicare Enrolled Practice Location: 106 13th St Apt 105, Charlestown, MA 02129 Phone: 267-229-6536 |
Ms. Agnes N Opara, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 529 Main St Ste 216, Charlestown, MA 02129 Phone: 617-600-3195 |
Ernsy Ala Dimanche, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 529 Main St, Charlestown, MA 02129 Phone: 617-600-3195 |
Erin Mcgee, RN Registered Nurse - Community Health Medicare: Not Enrolled in Medicare Practice Location: 529 Main St Ste 222, Charlestown, MA 02129 Phone: 866-610-2273 |
Augustina Ekes, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 529 Main St, Charlestown, MA 02129 Phone: 617-600-3195 |
Gabrielle Marie Paraison, Registered Nurse - Case Management Medicare: Not Enrolled in Medicare Practice Location: 529 Main St Ste 222, Charlestown, MA 02129 Phone: 617-426-0600 |
Olivia Harrison, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2 Monument Sq, Charlestown, MA 02129 Phone: 207-329-5301 |
News Archive
Although prescription drug misuse is on the decline among adolescents, one in two patients tested between the ages of 10 and 17 years are not using their medications appropriately, potentially putting their health at risk, according to an analysis by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services.
More than 100,000 people will develop colon cancer in 2007, according to the American Cancer Society; the disease currently causes more than 55,000 U.S. deaths annually.
Viruses that can invade host cells, initiate cancer and then flee fromb their own trail of destruction could be stopped in their tracks, say researchers writing in the September issue of the Journal of General Virology.
The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate), a type of chemotherapy, for the treatment of liposarcoma (a specific type of soft tissue sarcoma) that cannot be removed by surgery (unresectable) or is advanced (metastatic). This treatment is approved for patients who received prior chemotherapy that contained an anthracycline drug.
Novo Nordisk, a global healthcare company, announced today the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza® (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. Victoza is indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
› Verified 8 days ago